Heart MRI study aims to see how amyloid builds up over time
NCT ID NCT06073574
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 23 times
Summary
This study uses MRI scans to measure amyloid protein buildup in the heart of up to 150 people with a heart condition called ATTR-CM. Participants are already in a larger treatment study. The goal is to see how the amount of amyloid changes over time, not to test a new treatment. This helps researchers better understand the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN-MEDIATED AMYLOID CARDIOMYOPATHY (ATTR-CM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedale Università di Padova
Padova, 35128, Italy
-
Azienda Ospedaliero - Universitaria Careggi
Florence, 50139, Italy
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Hospital Universitario Puerta de Hierro
Majadahonda, 28222, Spain
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Richmond Pharmacology
London, SE1 1YR, United Kingdom
-
Royal Free London NHS Foundation Trust
London, NW3 2QG, United Kingdom
-
Synexus - Manchester Clinical Research Centre
Manchester, M15 6SE, United Kingdom
-
Synexus - Scotland Clinical Research Centre
Bellshill, ML4 3NJ, United Kingdom
-
Synexus - Wales
Cardiff, CF15 9SS, United Kingdom
-
Synexus Midlands Clinical Research Centre
Birmingham, B15 2SQ, United Kingdom
Conditions
Explore the condition pages connected to this study.